Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon [Phase 4]
Phase 4 trial update on the efficacy and safety of Sofosbuvir (Zoval) with or without Ribavirin and Interferon in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029) [Phase 1]
Phase 1 pharmacokinetic study assessing uprifosbuvir and ruzasvir in participants with moderate to severe hepatic impairment completed with …
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating single and multiple doses of Uprifosbuvir in healthy participants and those with chronic hepatitis C; co…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Swiss HCVree Trial [Phase 3]
Phase 3 clinical trial completed for an intervention targeting Hepatitis C and HIV.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. [Phase 4]
Phase 4 trial update for ledipasvir/sofosbuvir in hematopoietic stem cell transplant recipients has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C [Phase 4]
Phase 4 trial update examining serum alpha-fetoprotein levels and response to direct antiviral therapy in chronic hepatitis C patients.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant [Phase 2]
Phase 2 trial evaluating Sofosbuvir/Velpatasvir fixed-dose combination in liver transplant recipients with chronic hepatitis C; study comple…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection [Phase 2]
Phase 2 clinical trial update on liver cancer prevention in patients with chronic hepatitis C infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency [Phase 2]
Phase 2 trial comparing Sofosbuvir plus Ribavirin versus Ledipasvir/Sofosbuvir in adults with hepatitis C and renal insufficiency; results p…
-
CLINICAL_TRIALS trial_result · 2018-08-06Clinical Trial Update: Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035) [Phase 2]
Phase 2 trial update on Uprifosbuvir with Ruzasvir in chronic hepatitis C showing terminated status with posted results.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects [Phase 1]
This is a first-in-human Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of single and repeat escalating doses of GS…
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C. [Phase 1]
Phase 1 study of repeat-dose GSK2878175 in chronic hepatitis C completed; assesses safety, pharmacokinetics, and antiviral activity.
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus Infection [Phase 3]
Phase 3 clinical trial evaluating ABT-493/ABT-530 in Japanese adults with chronic hepatitis C virus infection has completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Impact of Sustained Virologic Response on Glycemic Control Among Diabetic Patients With Hepatitis C Virus Related Liver Disease
This clinical trial update investigates whether achieving sustained virologic response to hepatitis C treatment improves glycemic control in…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases
This completed pediatric trial from Baylor College of Medicine evaluated non-invasive biomarkers to detect liver fibrosis in children with v…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: The Safety and Efficacy of Daclatasvir and Asunaprevir With Chronic HCV Genotype 1b Infection and Chronic Renal Failure [Phase 4]
Phase 4 trial evaluating the safety and efficacy of Daclatasvir and Asunaprevir in hepatitis C genotype 1b patients with chronic renal failu…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination in Participants With Chronic Hepatitis C Virus Infection [Phase 3]
A Phase 3 trial update on the efficacy and safety of the Sofosbuvir/Velpatasvir fixed-dose combination for chronic hepatitis C virus infecti…
-
CLINICAL_TRIALS trial_result · 2018-07-16Clinical Trial Update: An Open-label Comparative Efficacy and Safety Study of Algeron (Cepeginterferon Alfa-2b) in Treatment-naive Patients With Chronic Hepatitis C [Phase 3]
This Clinical Trial Update describes a Phase 3 open-label study of Algeron (cepeginterferon alfa-2b) for treatment-naive chronic hepatitis C…
-
CLINICAL_TRIALS trial_result · 2018-07-13Clinical Trial Update: Multidisciplinary Support Program in Chronic Hepatitis C
A completed clinical trial evaluating a multidisciplinary support program for chronic hepatitis C; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects
A completed clinical trial evaluated the cerebral effects of pegylated interferon in hepatitis C patients, and the results have been posted.…
-
CLINICAL_TRIALS trial_result · 2018-07-12Clinical Trial Update: Clinical Performance Evaluation of DxN HCV Assay
A clinical trial evaluating the performance of Beckman Coulter's DxN HCV assay for Hepatitis C was terminated before completion.
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus Infection [Phase 2]
Phase 2 trial evaluating Ombitasvir/ABT-450/Ritonavir with Sofosbuvir with or without Ribavirin for chronic hepatitis C virus infection has …
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed-Dose Combination and Ribavirin for 12 or 24 Weeks in Participants With Chronic Genotype 1 or 2 Hepatitis C Virus Infection Who Have Previously Failed a Direct-Acting Antiviral-Containing Regimen [Phase 3]
Phase 3 study evaluating sofosbuvir/velpatasvir with ribavirin for 12 or 24 weeks in chronic hepatitis C genotype 1 or 2 patients who failed…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Efficacy and Safety of Grazoprevir (MK-5172) and Uprifosbuvir (MK-3682) With Elbasvir (MK-8742) or Ruzasvir (MK-8408) for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012) [Phase 2]
Phase 2 trial evaluating Grazoprevir with Uprifosbuvir with Elbasvir or Ruzasvir for chronic Hepatitis C across genotypes 3-6; study complet…
-
CLINICAL_TRIALS trial_result · 2018-06-29Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China [Phase 1]
A Phase 1 pharmacokinetics and safety study of ASC16 tablets in healthy volunteers in China has completed.